Literature DB >> 2118438

Standards for ANA and anti-DNA.

T E Feltkamp1.   

Abstract

A review of the history, production, characterics and availability of the standards and reference preparations in the field of ANA determination is given. For ANA of the homogeneous type and for anti-DNA standard reagents are recognized by the WHO. This enables the expression of quantitative results in international units, leading to a decrease of interlaboratory variations. For the other types of nuclear fluorescence and for anti-Sm, anti-Ro (SS-A), anti-La (SS-B), anti-Scl 70 and anti-Jo-1, reference reagents are made available by the Arthritis Foundation (AF) and the Centers for Disease Control (CDC) in the USA. For anti-nRNP, a WHO reference reagent exists. The use of the above materials is advocated. Requests for WHO standards should be directed to: Dept. of Reagents CLB, P.O. Box 9190, 1006 AD Amsterdam, The Netherlands, and for AF/CDC reagents to: AF/CDC ANA Ref. Lab., Immunology 1 - 1202 A 25, CDC, Atlanta GA 30333, USA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118438     DOI: 10.1007/bf02205554

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  The first international standard for antibodies to double stranded DNA.

Authors:  T E Feltkamp; T B Kirkwood; R N Maini; L A Aarden
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

2.  Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern.

Authors:  T E Feltkamp; F Klein; M B Janssens
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

3.  Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence.

Authors:  E H Beutner; E J Holborow; G D Johnson
Journal:  Immunology       Date:  1967-03       Impact factor: 7.397

4.  Defined immunofluorescent staining: past progress, present status, and future prospects for defined conjugates.

Authors:  E H Beutner
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

5.  Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La.

Authors:  E M Tan; M J Fritzler; J S McDougal; F C McDuffie; R M Nakamura; M Reichlin; C B Reimer; G C Sharp; P H Schur; M R Wilson; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-08

6.  Antinuclear-factor serum (homogeneous): an international collaborative study of the proposed research standard 66-233.

Authors:  S G Anderson; I E Addison; H G Dixon
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

7.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

  7 in total
  3 in total

1.  Antinuclear antibody determination in a routine laboratory.

Authors:  T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

2.  The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.

Authors:  H Bootsma; P E Spronk; E J Ter Borg; E J Hummel; G de Boer; P C Limburg; C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

Review 3.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.